Clinical Development Intern jobs in United States
cer-icon
Apply on Employer Site
company-logo

Corcept Therapeutics · 22 hours ago

Clinical Development Intern

Corcept Therapeutics is a leading biotech company focused on the research and development of cortisol modulators for treating serious diseases. The Clinical Development Intern will support the Clinical Development team in advancing programs in neurology and oncology through contributions to clinical development strategy and trial execution.

BiotechnologyMedicalPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Support literature reviews on neurology or oncology disease areas, treatment landscapes and emerging therapies
Support data review, analysis and interpretation from ongoing clinical trials, as appropriate
Participate in cross-functional team meetings
Network with other professionals and colleagues across the organization
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation

Qualification

Clinical research knowledgeAnalytical skillsProblem-solving skillsTeam collaborationPresentation skills

Required

Basic knowledge of clinical research and clinical trial regulations
Strong analytical and problem-solving skills
Ability to work independently and collaboratively in a dynamic team environment
Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week)
Must be able to work at our Redwood City office for the duration of the internship, no relocation available
Currently authorized to work in the United States on a full-time basis

Preferred

Currently enrolled in a graduate program (PharmD, MD, PhD) in a health-related field

Company

Corcept Therapeutics

twittertwittertwitter
company-logo
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.

Funding

Current Stage
Public Company
Total Funding
$119.09M
Key Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M

Leadership Team

leader-logo
Roberto Vieira
President, Oncology
linkedin
leader-logo
Yuan Xu
Associate Director, Statistical Programming
linkedin
Company data provided by crunchbase